Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

THC-HSΔ9-THC hemisuccinate

Prodrug ester of Δ9-THC, studied as a suppository to avoid hepatic first pass; never authorised.

Level of detail

C₂₅H₃₄O₅

CAS 52855-15-9

Family
Semi-synthetic cannabinoidEster or prodrug
Molar mass
414.54 g/mol

Updated on

In plain terms

THC hemisuccinate is a THC modified to be given as a suppository, so that a large part of the THC is not destroyed by the liver as when it is swallowed. In a 2018 study, this form delivered 2.44 times more THC into the blood than a capsule of the same dose. It has never been authorised as a medicine.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    Δ9-THC hemisuccinate is a prodrug ester of tetrahydrocannabinol studied for rectal administration, to get around the low and variable oral bioavailability of THC caused by gut metabolism and hepatic first pass (Mattes et al. 1993). Among several polar esters tested as suppositories in monkeys, only the hemisuccinate delivered Δ9-THC in a lipophilic base; its bioavailability was estimated at 13.5%, with a mean residence time of 5.8 hours against 3 hours intravenously (ElSohly et al. 1991). In dogs, it reached 67%. In three adult women, a suppository of 11.8 mg of ester (9 mg of THC) gave an area under the curve more than 30 times that of the oral form. In the 2018 study in male volunteers, Δ9-THC exposure after a 10 mg-equivalent suppository was 2.44 times that of a 10 mg dronabinol capsule. No marketing authorisation was found.

    History

    Source
    Absent from cannabis: it is an ester of Δ9-THC whose phenol function is esterified by succinic acid, the second acid function remaining free. It was designed as a prodrug for the rectal administration of Δ9-THC; no marketing authorisation was found.

    Route of preparation

    Chemical process

    No plant pathway. It is a semi-synthetic monoester of Δ9-THC (hemisuccinate at position 1), described here by chemical class only.

    Classification

    Family, origin and source verification

    Family

    Semi-synthetic cannabinoid › Ester or prodrug

    Chemistry

    C5 side chain · neutral form

    Verification

    Every fact on this entry was checked against its primary sources on 20 October 2026.

    Wikipedia (English)

    THC hemisuccinate (new tab)

    Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

    References

    Identifiers

    Names

    Common name
    Δ9-THC hemisuccinate
    IUPAC name
    4-[[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl]oxy]-4-oxobutanoic acid
    Other names
    THC hemisuccinate · THC-HS · Δ9-THC-hemisuccinate · dronabinol hemisuccinate

    Identifiers

    Formula
    C₂₅H₃₄O₅
    CAS
    52855-15-9
    PubChem CID
    162707(new tab)
    InChIKey
    YVOODUUYDJKFDY-RTBURBONSA-N
    SMILES
    CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)CCC(=O)O

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.